Dechra Veterinary Products
(A business unit of Dechra
Pharmaceuticals PLC)
Sansaw Business Park
Hadnall, Shrewsbury
Shropshire SY4 4AS
Tel: 01939 211200
damage to the liver. Photodermatitis often occurs in INTRAUTERINE PESSARY FOR CATTLE
areas of sparsely pigmented skin if these are exposedto sunlight. Allergic reactions are rare. In case of Qualitative and quantitative composition Each in-
allergic or anaphylactic reactions, discontinue treat- trauterine tablet contains: Active substance: ment immediately. Allergic reactions can be treated Tetracycline hydrochloride 2000.0 mg (equivalent parenterally with steroids and antihistamines.
Excipients: For a full list of excipients, see Excipi- Use during pregnancy and lactation: not indicated for use during pregnancy but can beused during lactation.
Pharmaceutical form
long-shaped tablet, scored on one side. The tablet is tween tetracyclines and antibiotics with bactericidalaction.
Clinical particulars
Target species: Cattle.
Amounts to be administered and administrationroute: Tablet for intrauterine use.
Cows: A dose of 2 g tetracycline hydrochloride per
post-parturient disorders in cattle: for administration treatment, equivalent to 1 tablet per cow, is to be following dystocia, retained foetal membranes and administered every 24 to 48 hours. The number of endometritis caused by pathogens susceptible to treatments required ranges from 1 to 3.
It is recommended to remove part of the lochia by by pathogens resistant to tetracycline.
rectal massage before treatment. Before administra- Do not use in severe kidney and liver disorders.
tion, the vulva and perineal area should be carefully Do not use in case of hypersensitivity to tetracy- washed and disinfected with a non-irritating solution and dried with disposable paper. Treatment shouldbe accompanied by an improvement in conditions of Special precautions for use in animals: The product should be used based on susceptibility testing and Overdose: Please refer to Adverse reactions.
take into account official, national and regional anti-microbial policies.
Special precautions to be taken by the person admin-istering the veterinary medicinal product to ani- Pharmacological
Direct contact with the skin or the mucous group: Anti-infectives and antiseptics for intrauterine membranes of the user should be avoided. The use of gloves is recommended when administering the product to avoid sensitisation. Wash your hands afterhandling the product.
broad-spectrum antibiotic with bacteriostatic action in vivo. The spectrum includes gram-positive and ful monitoring to avoid super-infection (for example gram-negative, aerobic and anaerobic micro-organ- with yeasts). Occurrence of renal disorders is en- isms. The primary pathogens involved in puerperal hanced in dehydrated animals. Tetracycline can cause intrauterine infections, Arcanobacterium (Actinomy- ces) pyogenes and Escherichia coli, are susceptible to tetracycline. For systemic action against most suscep- the outer carton in order to protect from light. Keep tible micro-organisms, in vivo serum concentrations out of the reach and sight of children.
of 0.5-2 μg/ml are considered efficacious, which need to be sustained over a sufficiently long period of time.
PVDC top foil and aluminium bottom foil.
Concentrations of more than 2 μg/ml of tetracycline Carton with 1 blister of 5 intrauterine tablets.
are easily obtained in lochia following intrauterine Carton with 2 blisters of 5 intrauterine tablets each administration of the recommended dose.
Carton with 4 blisters of 5 intrauterine tablets each Carton with 10 blisters of 5 intrauterine tablets each membranes is limited due to the amphotheric prop- Carton with 20 blisters of 5 intrauterine tablets each erties of the molecule. Absorption of tetracycline hydrochloride from the uterus to the peripheral blood Carton with 40 blisters of 5 intrauterine tablets each is limited in post-parturient cows. The rate of absorp- tion of tetracycline depends on various individual factors such as the relative blood flow to the myome-trium, contractions of the uterus, lochial volume, discharge from the vulva and the severity of inflam- or waste materials derived from such veterinary mation and infection. Tetracycline undergoes entero- medicinal products should be disposed of in accor- hepatic circulation and its antimicrobially active form is eliminated primarily via urine, faeces and milk. The Marketing authorisation holder (if different from
biological half-life following systemic administration distributor)
is 8 hours in ruminants. It varies depending on the 25, 5531 AE Bladel, The Netherlands.
route of administration; it is prolonged in animalswith renal insufficiency.
Marketing authorisation number Vm 16849/4021
Date of the first authorisation or date of renewal-
Pharmaceutical particulars
fate, sodium starch glycolate type A, microcrystalline Date of revision of the text June 2011
cellulose, silica colloidal anhydrous, magnesium ste- Any other information
To be supplied only on veterinary prescription.
Legal category POM-V
product as packaged for sale: 3 years.
GTIN (Global Trade Item No)
Do not use after the expiry date stated on the blister Bovocycline Pessary 2000 mg Intrauterine Pessary for Requested by: kate.gittins@dechra.com
Approved datasheets found: 1
Creation date: 10/10/2012 14:20:26 (UK)
Approved for book but not on website: 0
Datasheets marked as draft (ignored): 0
Directory of participants
Dechra Veterinary Products
(A business unit of Dechra
Pharmaceuticals PLC)
Sansaw Business Park
Hadnall, Shrewsbury
Shropshire SY4 4AS
Tel: 01939 211200Fax: 01939 211201email: info.uk@dechra.comwww.dechra.com LIST OF PRODUCTS BY THERAPEUTIC INDICATION List of Products by Therapeutic Indication
Uterine products
List of Products by Species
Please note that a species in brackets after a product name may not necessarily be a part of that product namebut is intended to make the index easier to use.
Bovocycline Pessary 2000 mg Intrauterine Pessary
List of Products by Active Ingredients
This index of non-proprietary names (active ingredients) is provided to enable users of the Compendium toidentify the brand names of relevant products when only the non-proprietary names are known.
It should be noted that although different products may contain the same active ingredient this does not implythat they are equivalent in regard to bioavailability or therapeutic activity.
Some products contain a number of ingredients and it has not been possible in every instance to identify suchproducts by a reference in this index to each ingredient.
Non-proprietary name in bold type. Proprietary name in ordinary type.
Tetracycline Hydrochloride
Bovocycline Pessary 2000 mg Intrauterine Pessary GRED

Alphabetical Index of Products

Source: http://dechra.co.uk/files/dechra/Downloads/Pharma/Datasheets/Bovocycline_Pessary_2000_mg_Intrauterine_Tablet-10-10-12.pdf

Microsoft word - a09-010a_determination_of_caffeine_in_beverages_using_uv_w…

SPECTROPHOTOMETER Application note: A09-010A The quantitative determination of caffeine in beverages and soft drinks using UV wavelength spectroscopy Introduction Caffeine is a naturally occurring alkaloid which is found in the leaves, seeds or fruits of over 63 solutions with chlorinated solvents such as plants species worldwide. The most common dichlormethane and chloroform, a tech

Microsoft word - pdf_10cibi-afrodisiaci.doc

I 10 cibi afrodisiaci La sana alimentazione che accende la passione! Nella settimana dedicata a San Valentino scopriamo 10 alimenti afrodisiaci, tra verità scientifiche e leggende metropolitane. Per la festa degli innamorati abbiamo in serbo per voi un nuovo menu di San Valentino da preparare in occasione di una cena romantica da dedicare al proprio partner. Se poi il

Copyright © 2014 Medical Pdf Articles